← All trials
NCT04851834
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 12, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Nov 30, 2023
- First posted
- Apr 20, 2021
- Last posted
- Jul 14, 2021
- Enrollment
- 125
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Xennials Therapeutics Australia Pty LtdLead sponsor
- Pinotbio, Inc.Collaborator
- Xennials Therapeutics Australia Pty LtdStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.